Abionyx Pharma Finalizes Manufacturing Process for Recombinant Human ApoA-I
Abionyx Pharma finalized an end-to-end manufacturing process for recombinant human ApoA-I with Axplora.
Abionyx Pharma finalized an end-to-end manufacturing process for recombinant human ApoA-I with Axplora.